Literature DB >> 7730247

Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?

B E Steinbrueckner1, U Steigerwald, F Keller, K Neukam, O Elert, J Babin-Ebell.   

Abstract

A number of hemostatic parameters reflecting the activation of coagulation and fibrinolysis were investigated in a prospective study of 24 patients undergoing cardiopulmonary bypass (CPB) during heart surgery. The patients were randomized to a group in which either a roller (group 1) or a centrifugal pump (group 2) was used. Blood samples were taken preoperatively, at the onset of and every 20 min during CPB, after the administration of protamine, and 4, 20, 44, and 68 h postoperatively. The groups did not differ significantly in hematocrit, fibrinogen, factor XIII, and antithrombin III. Significant differences in favor of group 2 during and after CPB were found in prothrombin fragment F1 + 2, plasmin-antiplasmin complex (PAP), thrombin-antithrombin complex (TAT), and D-dimer (F1 + 2 P < 0.01 after 80-min CPB, PAP P < 0.005 after 40-min CPB, TAT and D-dimer P < 0.05 after 100-min CPB, D-dimer and PAP P < 0.05 after protamine administration, TAT and F1 + 2 4 h after CPB). These findings indicate the activation of fibrinolysis preceding thrombin generation during cardiopulmonary bypass. In addition, we conclude that centrifugal blood pumping is beneficial in avoiding excessive activation of both coagulation and fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730247     DOI: 10.1007/bf01745077

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  27 in total

1.  Reoperation and the centrifugal pump?

Authors:  H Jakob; G Hafner; S Iversen; U Hake; C Thelemann; W Prellwitz; H Oelert
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191

2.  Effects of pulsatile and nonpulsatile perfusion mode during extracorporeal circulation--a comparative clinical study.

Authors:  F Dapper; H Neppl; G Wozniak; I Strube; B Zickmann; F W Hehrlein; H Neuhof
Journal:  Thorac Cardiovasc Surg       Date:  1992-12       Impact factor: 1.827

3.  Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation.

Authors:  O Kucuk; H C Kwaan; J Frederickson; L Wade; D Green
Journal:  Am J Hematol       Date:  1986-11       Impact factor: 10.047

4.  Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.

Authors:  Y Sakata; S Curriden; D Lawrence; J H Griffin; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 5.  Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs.

Authors:  H Fritz; G Wunderer
Journal:  Arzneimittelforschung       Date:  1983

6.  Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.

Authors:  E F Plow
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

7.  Activation of coagulation after administration of tumor necrosis factor to normal subjects.

Authors:  T van der Poll; H R Büller; H ten Cate; C H Wortel; K A Bauer; S J van Deventer; C E Hack; H P Sauerwein; R D Rosenberg; J W ten Cate
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

8.  Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator.

Authors:  J Stibbe; C Kluft; E J Brommer; M Gomes; D S de Jong; J Nauta
Journal:  Eur J Clin Invest       Date:  1984-10       Impact factor: 4.686

9.  Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig.

Authors:  L Nilsson; K E Storm; S Thelin; L Bagge; J Hultman; J Thorelius; U Nilsson
Journal:  Artif Organs       Date:  1990-02       Impact factor: 3.094

10.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

2.  Interindividual variations in cytokine levels following cardiopulmonary bypass.

Authors:  M Misoph; J Babin-Ebell
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

3.  Reduced release of tissue factor by application of a centrifugal pump during cardiopulmonary bypass.

Authors:  J Babin-Ebell; M Misoph; W Müllges; K Neukam; O Elert
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

4.  Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation.

Authors:  R Grossmann; J Babin-Ebell; M Misoph; S Schwender; K Neukam; T Hickethier; O Elert; F Keller
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

5.  Which factors have a great impact on coagulopathy and hemostatic impairment after cardiopulmonary bypass in cardiovascular surgery? An analysis based on rotational thromboelastometry.

Authors:  Kenshi Yoshimura; Hirotsugu Hamamoto; Takafumi Abe; Norio Itai; Shuichiro Uehara; Takuya Tsusue; Satomi Tahara; Hideo Iwasaka; Hiroki Sato; Shinji Miyamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.